Below are the most recent publications written about "Teriparatide" by people in Profiles.
-
Mikula AL, Lakomkin N, Hamouda AM, Everson MC, Pennington Z, Kumar R, Pinter ZW, Martini ML, Bydon M, Kennel KA, Baffour F, Nassr A, Freedman B, Sebastian AS, Abode-Iyamah K, Anderson PA, Fogelson JL, Elder BD. Change in spinal bone mineral density as estimated by Hounsfield units following osteoporosis treatment with romosozumab, teriparatide, denosumab, and alendronate: an analysis of 318 patients. J Neurosurg Spine. 2024 09 01; 41(3):309-315.
-
Mikula AL, St Jeor JD, Naylor RM, Bernatz JT, Patel NP, Fogelson JL, Larson AN, Nassr A, Sebastian AS, Freedman B, Currier BL, Bydon M, Kennel KA, Yaszemski MJ, Anderson PA, Elder BD. Teriparatide Treatment Increases Hounsfield Units in the Thoracic Spine, Lumbar Spine, Sacrum, and Ilium Out of Proportion to the Cervical Spine. Clin Spine Surg. 2021 08 01; 34(7):E370-E376.
-
Flanigan PM, Mikula AL, Peters PA, Oushy S, Fogelson JL, Bydon M, Freedman BA, Sebastian AS, Currier BL, Nassr A, Kennel KA, Anderson PA, Polly DW, Elder BD. Regional improvements in lumbosacropelvic Hounsfield units following teriparatide treatment. Neurosurg Focus. 2020 08; 49(2):E11.
-
Wanderman N, Alvi M, Yolcu Y, Carlson B, Sebastian A, Bydon M, Freedman B. Is Teriparatide Beneficial to Spinal Fusion Surgery in the Older Patient?: A Narrative Review. Clin Spine Surg. 2019 06; 32(5):182-190.
-
Yolcu Y, Alvi M, Wanderman N, Carlson B, Sebastian A, Bydon M, Freedman B. Effect of teriparatide use on bone mineral density and spinal fusion: a narrative review of animal models. Int J Neurosci. 2019 Aug; 129(8):814-820.
-
Qaseem A, Forciea MA, McLean RM, Denberg TD, Barry MJ, Cooke M, Fitterman N, Harris RP, Humphrey LL, Kansagara D, McLean RM, Mir TP, Sch?nemann HJ. Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians. Ann Intern Med. 2017 06 06; 166(11):818-839.
-
Bialo SR, Gordon CM. Underweight, overweight, and pediatric bone fragility: impact and management. Curr Osteoporos Rep. 2014 Sep; 12(3):319-28.
-
Foster SA, Foley KA, Meadows ES, Johnston JA, Wang SS, Pohl GM, Long SR. Adherence and persistence with teriparatide among patients with commercial, Medicare, and Medicaid insurance. Osteoporos Int. 2011 Feb; 22(2):551-7.
-
Foster SA, Foley KA, Meadows ES, Johnston JA, Wang S, Pohl GM, Long SR. Characteristics of patients initiating teriparatide for the treatment of osteoporosis. Osteoporos Int. 2008 Mar; 19(3):373-7.
-
Li J, Duncan RL, Burr DB, Gattone VH, Turner CH. Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. Endocrinology. 2003 Apr; 144(4):1226-33.